Basics |
Embecta Corp.
|
IPO Date: |
April 1, 2022 |
Sector: |
Healthcare |
Industry: |
Drug Manufacturers - Specialty and Generic |
Market Cap: |
$874.94M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.44 | 2.19%
|
Avg Daily Range (30 D): |
$0.26 | 2.05%
|
Avg Daily Range (90 D): |
$0.29 | 2.51%
|
Institutional Daily Volume |
Avg Daily Volume: |
.47M |
Avg Daily Volume (30 D): |
.45M |
Avg Daily Volume (90 D): |
.45M |
Trade Size |
Avg Trade Size (Sh.): |
61 |
Avg Trade Size (Sh.) (30 D): |
52 |
Avg Trade Size (Sh.) (90 D): |
56 |
Institutional Trades |
Total Inst.Trades: |
1,365 |
Avg Inst. Trade: |
$2.25M |
Avg Inst. Trade (30 D): |
$1.5M |
Avg Inst. Trade (90 D): |
$1.53M |
Avg Inst. Trade Volume: |
.1M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.5M |
Avg Closing Trade (30 D): |
$1.54M |
Avg Closing Trade (90 D): |
$1.54M |
Avg Closing Volume: |
115.85K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$.78
|
$.4
|
$
|
Diluted EPS
|
$.78
|
$.4
|
$
|
Revenue
|
$ 295.5M
|
$ 259M
|
$ 261.9M
|
Gross Profit
|
$ 197.1M
|
$ 164.1M
|
$ 157.1M
|
Net Income / Loss
|
$ 45.5M
|
$ 23.5M
|
$ M
|
Operating Income / Loss
|
$ 94M
|
$ 62.9M
|
$ 28.7M
|
Cost of Revenue
|
$ 98.4M
|
$ 94.9M
|
$ 104.8M
|
Net Cash Flow
|
$ 18.2M
|
$
|
$
|
PE Ratio
|
19.12
|
|
|
|
|
|